Search

everythinglearnresearchcommunity

for

Search:↓

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Tailor treatments for vitiligo to patient needs for best results.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

Hair quality is genetically determined and linked to its composition and strength.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

Physical activity, height, and smoking affect prostate cancer risk.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Children need early diagnosis and treatment for iron-deficiency anemia to prevent learning problems and promote health.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

The pandemic changed how often certain skin conditions were diagnosed.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Finasteride's potential harms are hard to accurately measure.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

PCOS is a major cause of infertility in women of childbearing age.

Only anti-androgenic drugs likely halt AGA progression.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.